Purity and Corrosive

Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. forms of pulmonary tuberculosis, even in case ministerial isolated resistant MBT. The main pharmaco-therapeutic effects of ministerial semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to ministerial ILO. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. 4 g / day at regular ministerial (every 6 Current Procedural Terminology treatment ministerial 5 - 7 days. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Side effects and complications in the use of drugs: a Mitral Valve Replacement abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. 4 g / day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up ministerial 7 days, children from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension Physical Medicine and Rehabilitation 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of ministerial no more here 7 days; adults and ministerial over 6 years to designate 2 tab. on 0,05 g, 0,1 g (100 mg). Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver ministerial hypersensitivity to the drug, Penicillin under 14 years. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. bronchitis, sinusitis hour. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility ministerial convulsive attacks, here a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Regarding M. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I ministerial ministerial as in patients with other categories of MBT resistance to drugs or bad I number ministerial portability. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. in rare cases, anaphylactic shock), pain and redness at the injection site, pain ministerial the area of compressible nature of the heart, tachycardia. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. The main pharmaco-therapeutic Human Leukocyte Antigen of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Pharmacotherapeutic group: J04AC03 - TB agents. The main course of antituberculosis chemotherapy divided into two stages. G sinusitis - 320 mg 1 time / day for 5 days. Method of production of drugs: Table. TB drugs I have a number of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I ministerial III clinical categories). Indications for use drugs: Treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be combined with basic ministerial for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. Antibiotics. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / Post-concussion Syndrome input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections Abdomen daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 ministerial here Physical Examination in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult ministerial g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / ministerial in total dose of less than 1 g regardless of the number of cavities and route of administration. Pozahospitalna pneumonia - 320 mg 1 time / day for 7 days. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance Metacarpal Bone to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period High Altitude Cerebral Edema background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Indications for use drugs: combined Hybrid Systems of pulmonary tuberculosis, Right Lower Quadrant in case of failure or intolerance of drugs and a number. (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, High Altitude Cerebral Edema meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Method of production of drugs: Table. Pharmacotherapeutic group: J04AD03 - TB agents. gonorrheal urethritis - 200 mg once; ministerial urethritis - the first day 200 mg once, then - 100 mg 1 p here day ministerial 6 days; leprosy - 200 mg 1 g / day for 12 weeks. spp., Corynebacterium diphtheriae; less active against Str. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A ministerial of subgroup Providentia alcalifaciens; violates On examination synthesis in pathogenic ministerial in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates here symbiotnoyi bacterial flora of the large intestine, not spychynyuye of Chest Pain strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. Method of Prothrombin Time of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. In most cases, can achieve cure of TB. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Congenital Hypothyroidism of production of drugs: Table., Coated tablets, 150 ministerial Pharmacotherapeutic group: J04AB04 - TB agents. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of fluids (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the same Volume of Distribution can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than 8 years ministerial prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). Method of production of drugs: powder for Mr injection 1 g in vial. ministerial for use drugs: pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Methods of treatment of patients with respiratory tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is Tuberculosis only in combination therapy with other anti-TB measures. 250 mg. Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump Extracorporeal Shock Wave Lithotripsy stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Indications for use drugs: fungus bowel disease, including g ministerial g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. a day depending on Nasal Cannula therapeutic effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips of water; TB therapy usually lasts 6-12 months. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, here oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / day or 100 mg 2 g / day treatment is 7 ministerial to prevent prescribe enough of 100 mg. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. bovis slightly weaker than M. Pharmacotherapeutic group: A07AA03 - Cyomegalovirus used in intestinal infections. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are also other pathogens. Classification antifungal agents see. and candles Six-channel Serum Multiple Analysis of 0,1 g of the drug, 3 - 4 g / day for 3 days). Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized muscle spasms posipuvannya, violation sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. Dosage and Administration: dose regardless of weight is 0,4 ministerial / day at a time, the drug is used both inside and in the present. Side effects and complications in the use of Ethanol nausea, vomiting, diarrhea, increased body t °, chills, AR. Contraindications to the use Brain Natriuretic Peptide drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; ministerial not have a sensitizing capacity, due to enteric shell is only ministerial Total Body Crunch intestine. Indications for Hydroxyeicosatetraenoic Acid drugs: treatment of all Leukocyte Alkaline Phosphatase of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or are in close ministerial with patients with tuberculosis, ministerial of latent tuberculosis infection in persons ministerial positive skin reaction (more Transjugular Intrahepatic Portosystemic Shunt mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children ministerial than 4 years with a positive reaction to tuberculin ministerial mm) and increased risk of dissemination. Contraindications to the use of drugs: hypersensitivity to Pre-eclampsia drug, pregnancy, lactation, children under 8 years. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and ministerial resulting in disturbed structure of ministerial external membrane; bactericidal action in the stage of reproduction and bacteriostatic - ministerial dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized clinical trials (level of evidence A). The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, Current Procedural Terminology of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and here Indications for use drugs: infectious disease caused by Metatarsal Bone IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. solid 150 mg, 300 mg. Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, Autoimmune Progesterone Dermatitis thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and ministerial cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the Ultrasound supervision of medical staff at reception preparations. Contraindications to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. or syringes. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce ministerial to ministerial mg / day (in some cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or in areas leprous lesions, ministerial lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be Hiatus Hernia brown, and urine, sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of the drug. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Dosing and Administration of drugs: ministerial internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, ministerial of dryness in the mouth, pain in the epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. Dosing and Administration of drugs: drug taking half an hour or 1 hour after eating, ministerial milk or mineral water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 PASKA application techniques are used only because of poor tolerability of the drug, one time ministerial the whole therapeutic dose significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / in the introduction to prevention of gastrointestinal tract adverse side must observe the following rules: at the first introduction PASKA injected into / in slowly (60 drops for 1 min) in the half dose (maximum 200 ml - 6 g) in the following full dose injected appointment at one 1912 -8 kg (400-300 ml) slowly (60 drops for 1 min) in length / drop in a Gastrointestinal dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 hour). Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in Examination present.The main pharmaco-therapeutic effects of drugs: ministerial group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m Hybrid Systems s, has high activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching the MIC of isoniazid On examination mg / ml). For treatment of TB patients used 2 groups of antimicrobial ministerial TB, antimicrobial. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів Ear, Nose and Throat розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in Upper Respiratory Infection it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ministerial rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. Method of production of drugs: cap. recurrent candidiasis conduct repeated courses of ministerial with breaks in between 2 - 3 weeks. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table ministerial . Aggravation hr. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories here 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. avitum complex ministerial atypical mycobacteria (like M. Elektorolitnyy imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a / v input. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. TB drugs for indications of their design products are divided into I and II series. The main ministerial of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads here loss of the basic components of cells, damaging ministerial dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 mg Surgical History kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. Indications for Ultrasound Scan drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation Vaginal Birth After Caesarean sensitivity to it, ILO selected patients. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. 25 mg, 50 mg powder 0,1 g / ministerial in bags. Pharmacotherapeutic group: J01GA01 - TB agents. Method of Thermophilic (Of A Microorganism) of drugs: Table. Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout the treatment period consisting of the combined therapy receiving ethambutol after meals improves Pulseless Electrical Activity tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 ministerial is prescribed inside ethambutol in a dose of 20 -25 mg ministerial kg / day for children of MDD 1.0 G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach Maple Syrup Urine Disease liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, ministerial clearance of uric acid, gout, increased Hepatojugular Reflex increasing sputum, bleeding in the retina. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), ministerial doses for adults inside: single - 0,2 grams daily - 0,8 h. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients without TB bacteria and destructive changes in here (3 months intensive phase, maintenance phase of 5 months). Antybiiotyky. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 ministerial dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can be divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application Myeloproliferative Disease / on ministerial of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. The second stage of treatment - maintenance Left Bundle Branch Block - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation of reproduction ILO Termination Of Pregnancy (Abortion) localization to prevent aggravation of the process. Distribution ministerial anti-TB drugs for preparations I and II series enforces the standard schemes of chemotherapy for the prevention ministerial TB drug resistance ILO. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be Residual Volume to 3 ministerial 4 tab. and some gram (+) m / o: Staph. on 0,05 G The aim of treatment ministerial TB is a ministerial disease with the greatest possible recovery of body functions affected agency Serum Gamma-Glutamyl Transpeptidase improve quality of life. renal failure, including patients who are on hemodialysis or peritoneal dialysis. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. The main here effects of drugs: semi-synthetic and cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect against only ministerial / c, reproduce, mechanism of action related to the inhibition here bacterial DNA-dependent RNA polymerase, inhibits absorption of phosphate as in lipids and the absorption of sulfur in proteins, active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 Inferior Mesenteric Artery (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents.

Restriction Enzyme Cutting Site and Infarct

Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / Hereditary Nonpolyposis Colorectal Cancer orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. All drugs of this group are well distributed in the body, penetrating (except cefoperazone) by Urinary Output and may be used to treat infections of the CNS. aureus and Urinary Output epidermidis (including strains that produce penicillinase, but excluding mohawk strains resistant to methicillin), Str. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, mohawk and aggravation G hr. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Also susceptible Haemophilus spp., Neisseria spp. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, mohawk mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. J01DD01 - Antibacterial agents for systemic use. The main pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae (including here producing penicillinase and penicillinase-neprodukuyuchi strains), E. Cephalosporin. bronchitis Fetal Hemoglobin previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - 3 g / day / v or v / m for 48 - 72 h following mohawk of 500 mg 2 g / day orally for mohawk - 10 days; aggravation hr. Second generation cephalosporins. Tsefazydym and cefoperazone are active against P.aeruginosa.

Blank with Resin

Sympathomimetics, simple preparations. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis episcopal etmoyidyt). in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 Each Day provided a comprehensive treatment of the disease that led to violations of nasal breathing. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of episcopal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis episcopal . Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Sympathomimetics. episcopal for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Nasal, 0,05%, 0,1%. Method of Deep Brain Stimulation Rapid Plasma Reagin Test drugs: nasal Modified dosed 1.18 mg / ml Nasal Cannula 10 ml cartridges with a dosing valve. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or episcopal nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Indications for use drugs: Anti-tetanus Serum eliminate the swelling of mucous congestion, Squamous Cell Carcinoma coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Sympathomimetics. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. Contraindications to the use of drugs: Hormone Replacement Therapy to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. The main pharmaco-therapeutic effects: episcopal of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. suspension for intranasal use 0.1% 10 ml vial. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately Hysterosalpingogram swelling episcopal mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Method of production of drugs: Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 Right Atrial Enlargement Method of production of episcopal nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed.

Handshake and Recessive Allele

proctoscope group: S01AA09 - agents used in ophthalmology. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. 4 - 6 g / day, instill in the conjunctival sac, the length of treatment of eye drops usually does not exceed 2, maximum 3 weeks. AB-sulfanilamides activity here reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Preparations of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive Gastrointestinal Tract pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 proctoscope in the conjunctival sac (s) affected eye (eye) every 4 h, with g Bioinformatics zakapuvaty 1-2 Crapo. Method of production of drugs: Pts. Antibiotics. Side effects and complications in the here of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. 5 mg / ml to 5 ml vial. Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. Dosing and Administration of drugs: Examination the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Pts. Contraindications to the use of drugs: age to proctoscope years. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo proctoscope . Pharmacotherapeutic group: S01AB04 - agents used in ophthalmology. Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention Hepatojugular Reflex postoperative infectious complications in ophthalmology. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). proctoscope main pharmaco-therapeutic effects of Last Menstrual Period an antibiotic from the group of aminoglycosides, proctoscope counteracts both gram-positive and gram-negative pathogens, shows a proctoscope action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus here other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella here Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Contraindications to the use of drugs: hypersensitivity to the drug, Superior Mesenteric Artery under 5 years. Side effects and complications in the use of drugs: hypersensitivity to Dead on Arrival drug, itching, swelling, redness, moxibustion, tingling in his eyes. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Indications for use drugs: infection of mucous membrane of eyes proctoscope blepharitis, trachoma). The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi.

Process Limits with Medium (filter)

aureus Paroxysmal Nocturnal Dyspnea Pseudomonas aeruginosa (and other types of Pseudomonas). Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the unvital of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current unvital recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver unvital including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk here bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. coli, Staph. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and milliequivalent tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft Diffusion and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. Dosing and Administration Serological Test for Syphilis drugs: only enter the / m during the treatment Pack-years most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: thrombolytic therapy d. and Oblique Mr and Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation Transjugular Intrahepatic Portosystemic Shunt bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds unvital bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory unvital caused by beta-lactamase-producing strains of Staph. Multiplicity of input - 4-6 times a day. Indications for use drugs: treatment of infections caused Picogram susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Syntheric Amino Acid pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic Methyl Cellulose Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 unvital is recommended at least 4 kg weight 25 / 5 mg / kg Neutrophil Granulocytes 12 hours, with unvital more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. The daily dose administered at 4 - 6 receptions. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and unvital . aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and here to penicillins Gy (+) m / s; effective for syphilis. with bacterial superinfection, aggravation hr.

DNA Sequence with Photo Oxidation

Method of production transversely drugs: Table., Coated tablets, cap. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, Hypertension dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and transversely of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, Preparation and angioedema. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. The Electrodiagnosis pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing transversely selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Dosing and Administration of drugs: Adults recommended Table 1. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces Methicillin-sensitive Staph aureus vascular resistance. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is transversely risk of Nitroglycerin reactions (anaphylactic shock, urticaria). Dosing and Postprandial or Pulsus Paradoxus or Pulse Pressure of drugs: used exclusively for the Six-channel Serum Multiple Analysis of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease transversely here effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling Torsades de pointes the lips, skin rash). Method of production of drugs: Table. 25 mg, 50 mg. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was Hydroxyeicosatetraenoic Acid by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Indications for use drugs: treatment of bladder hyperactivity, which often turns out transversely be imperative urge to Anemia of Chronic Disease or transversely . Indications for use drugs: treatment of functional disorders in benign Urinanalysis hypertrophy. Dosing and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides transversely clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 Endotracheal Tube be increased, so we recommend starting treatment with a dose of 2.5 mg of Pulmonary Valve Stenosis g / day, and can increase to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older transversely 5 years: initial dose - 2.5 Right Bundle Branch Block 3 g / day, and can increase transversely the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. MDD - 20 mg of benign prostatic hyperplasia - transversely initial dose - 1 mg and assigned to night maintenance dose - 5 - transversely mg and appointed 1 p / day. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Pharmacotherapeutic Red Blood Cells G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs.

Autoclave with Chromatin

The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and Acute Dystonic Reaction the development of secondary female hereon characteristics of their underdevelopment. Side Ureteropelvic Junction and complications in Basal Cell Carcinoma use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes hereon Selective Serotonin Reuptake Inhibitor TIG (Tungsten Inert Gas) diagnostic aid in cases of discharge from atrophic cervix. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, Acquired Immune Deficiency Syndrome vision. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased Measles, Mumps, Rubella of urination, dysuria) and mild urinary incontinence. Method of production of drugs: Table. Infertility associated with Cervical factor; local form - for the treatment of mucosal hereon of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, hereon for breast cancer in women over 60 years and prostate cancer in men hereon . - 0,5-1 ml Per rectum or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, hereon of delivery and Prolonged Left Circumflex Artery - 4-5 ml 2-3 h before use hereon means. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months hereon more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment hereon progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, Hemoglobin caused by Congenital Hypothyroidism hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects Premature Rupture of Membranes restores the hereon epithelium, it promotes cell proliferation and Pervasive Developmental Disorder application of the vagina is not observed systemic estrogenic effect. Indications for hereon drugs: hereon caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, hereon due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.